PRESS RELEASE published on 10/16/2025 at 12:00, 4 months 28 days ago Supreme Critical Metals Inc. Silver Vista Silver-Copper Property Site Visit, Smithers, BC Supreme Critical Metals Inc. reviews data on Silver Vista property, focusing on silver-copper mineralization. Drilling results show high silver and copper grades. Permitting in progress for future exploration Drilling Results Permitting Supreme Critical Metals Inc. Silver Vista Property Silver-copper Mineralization
PRESS RELEASE published on 10/16/2025 at 11:45, 4 months 28 days ago Banyan Announces Closing $31.4 Million Private Placement with Strategic Investor Banyan Gold Corp. announces the closing of a non-brokered private placement, issuing flow-through shares and common shares, for gross proceeds of $31,389,000, with support from Alpayana S.A.C. Offering subject to TSXV approval Private Placement TSX Venture Exchange Banyan Gold Corp. Mining Alpayana S.A.C.
PRESS RELEASE published on 10/16/2025 at 11:15, 4 months 28 days ago Fiscal Year 2024 - 2025: Revenue +28.6% to EUR 4,064K, EBITDA at EUR 1,145K MACOMPTA.FR reports strong financial performance for FY 2024/2025 with revenue growth of 28.6% to €4,064K, EBITDA at €1,145K, and proposes a dividend of €325K. The company focuses on software solutions for businesses and accountants Financial Results EBITDA Revenue Growth Software Solutions Macompta.fr
PRESS RELEASE published on 10/16/2025 at 11:13, 4 months 28 days ago Contract of Knorr-Bremse Executive Board member Nicolas Lange extended by five years Knorr-Bremse extends Dr. Nicolas Lange's contract as Executive Board member for five years, showcasing strategic leadership in the Rail Vehicle Systems division Contract Extension Executive Board Knorr-Bremse Rail Vehicle Systems Nicolas Lange
PRESS RELEASE published on 10/16/2025 at 11:05, 4 months 28 days ago Smart City Expo Doha envisions a prosperous future beyond connectivity Smart City Expo Doha envisions a prosperous future beyond connectivity. The event will focus on digital solutions for urban environments, featuring renowned speakers and thematic areas Innovation Technology Digital Solutions Urban Environments Smart City Expo Doha
PRESS RELEASE published on 10/16/2025 at 11:05, 4 months 28 days ago Tomorrow.Building targets the housing crisis to lay the foundation of a smarter construction Tomorrow.Building World Congress in Barcelona to address housing crisis and smart construction solutions with global experts, alongside other urban-focused events Innovation Urban Development Housing Crisis Tomorrow.Building Smart Construction
PRESS RELEASE published on 10/16/2025 at 11:05, 4 months 28 days ago Andera Partners co-leads €105 million Series A round for Adcytherix, its first investment from the BioDiscovery 7 fund Andera Partners co-leads €105 million Series A funding round for Adcytherix, marking the first investment from BioDiscovery 7 fund to advance novel ADC programs for cancer treatment Andera Partners ADC Series A Adcytherix BioDiscovery 7
PRESS RELEASE published on 10/16/2025 at 11:00, 4 months 28 days ago ABB Ltd: ABB share buybacks - October 9, 2025 - October 15, 2025 ABB repurchased 240,065 shares from October 9 to October 15, 2025, part of the share buyback program. Transactions comply with financial regulations. More details on ABB's investor relations website Investor Relations Share Buybacks ABB Financial Regulations Repurchase Program
PRESS RELEASE published on 10/16/2025 at 10:30, 4 months 28 days ago Inside Information / Other news releases TP and UNICEF renew partnership to support education programs and humanitarian response, creating safer learning environments and providing support to vulnerable children worldwide Partnership Education Programs TP UNICEF Humanitarian Response
PRESS RELEASE published on 10/16/2025 at 10:10, 4 months 28 days ago C-Path's Disease Modeling Coalition Begins Global Pediatric IBD Work from European Hub Critical Path Institute launches Disease Modeling Coalition to accelerate pediatric IBD drug development with experts from ESPGHAN and support from Crohn's & Colitis Foundation Drug Development Pediatric IBD Critical Path Institute Disease Modeling Coalition Crohn's & Colitis Foundation
Published on 03/13/2026 at 12:00, 4 minutes ago Athena Completes Acquisition of Forester Gold Project Near Orla Mining’s Musselwhite Mine
Published on 03/13/2026 at 00:30, 11 hours 34 minutes ago AI/ML Innovations Inc. Announces Proposed Private Placement of Convertible Debentures
Published on 03/12/2026 at 22:55, 13 hours 9 minutes ago Faraday Copper Reports 2025 Financial Results
Published on 03/12/2026 at 22:15, 13 hours 49 minutes ago Avidian Gold Announces the Appointment of a New Director
Published on 03/12/2026 at 22:00, 14 hours 4 minutes ago Onco-Innovations Announces Closing of Private Placement
Published on 03/13/2026 at 11:48, 16 minutes ago Nemetschek Group proposes dividend increase by around 24% to EUR 0.68 per share for 2025
Published on 03/13/2026 at 11:05, 59 minutes ago Alimentaria+Hostelco 2026 reinforces its leadership in a historic edition
Published on 03/13/2026 at 09:32, 2 hours 32 minutes ago Klöckner & Co SE Management and Supervisory Boards reiterate recommendation to accept Worthington Steel takeover offer
Published on 03/13/2026 at 09:00, 3 hours 4 minutes ago Original-Research: Netfonds AG (von NuWays AG): SELL
Published on 03/13/2026 at 09:00, 3 hours 4 minutes ago Original-Research: MLP SE (von NuWays AG): BUY
Published on 03/13/2026 at 07:30, 4 hours 34 minutes ago BIOPHYTIS PRESENTS ITS DEVELOPMENT PROGRAMS IN OBESITY AND SARCOPENIA AT THE ICFSR CONFERENCE
Published on 03/12/2026 at 18:00, 18 hours 4 minutes ago NEW OR RENEWED AGREEMENTS BETWEEN EURAZEO AND CERTAIN FAMILY SHAREHOLDERS
Published on 03/12/2026 at 15:06, 20 hours 58 minutes ago FIERA MILANO: THE BOARD OF DIRECTORS APPROVES THE CONSOLIDATED RESULTS AS OF 31 DECEMBER 2025
Published on 03/12/2026 at 10:55, 1 day 1 hour ago Statement of transactions in own shares on March 9th, 2026
Published on 03/12/2026 at 07:30, 1 day 4 hours ago Biophytis-LynxKite Alliance Expands to Turbocharge AI-driven drug discovery for next generation longevity therapeutics